Authors showed that estrogen activates the AKT pathway in BRCA1-deficient mammary tumors by enhancing the expression of p-Akt, p-mTOR, p-Gsk3 β, and p-4Ebp1, downstream targets of Akt. The gene discussed is AKT1; the disease is breast cancer.